Dan Mendelson, MPP, founder, Avalere Health, outlines the impact recent healthcare policy changes have on pharmacists and providers.
Dan Mendelson, MPP, founder, Avalere Health, outlines what recent healthcare policy changes Avalere Health is paying the most attention to.
TranscriptWhat recent healthcare policy changes has Avalere Health been paying the most attention to?
This is a really vibrant and rapidly changing environment, and I think it’s important for pharmacists to understand that they are really living in a context of a lot of change. A lot of the change is focused around the health plan world. So, health plans today are increasingly being asked to take risk, to improve quality for patients, and really to start to integrate some of the pharmacy offerings into the medical aspects of the offerings. So, the plan environment is changing rapidly, quality measures are really driving a lot of the activity in plans, and that’s kind of the first major piece that’s of relevance.
Second, I’d say that in the provider world, a lot of those incentives that the plans are under are now trickling down into the provider space. I mean, providers know that they are not going to be the one to immunize the patient, they’re not going to be the ones to hand them their medication. So, the plans know that, and the providers ultimately need to be aligned into the kinds of incentives that exist in that context. So, that’s another aspect.
I’d say also that the individual markets are important for pharmacists. The reality is that the individual markets are small as a percentage of total markets but are driving a lot of the trends that we are seeing: high-deductible health plans, restrictive networks, and the like. So, those are some of the things we’re most focused on, and I think kind of speak to the importance of understanding the change environment.
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
SABCS 2023 Sessions Touch on "Every Aspect of Breast Cancer"
December 4th 2023The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Evaluating Label Warnings, Switching Rates in Patients With Psoriasis Initiating New Treatment
November 9th 2023Posters presented at the 2023 Fall Clinical Dermatology Conference evaluated how label warnings may affect new treatment initiation and real-word switching patterns for patients starting risankizumab.
Read More
Innovation in Value-Based Care Requires More Data, Patient-Centered Thinking
November 9th 2023In a panel discussion at the 2023 Patient-Centered Oncology Care® meeting held in Nashville, Tennessee, experts discussed the Enhancing Oncology Model and themes in the movement toward value-based care in oncology.
Read More